03/03/2022
The production of 20 vital and essential medicines is planned to be launched in SEZ Technopolis Moscow by the end of 2022.
The SEZ resident received a license for the production of medicines and an EAEU GMP certificate confirming compliance with high production quality standards. By the end of 2022, the company plans to launch production of 20 drugs for the treatment of HIV infection, cancer, kidney failure, as well as anticoagulants, chelators and insulins. The first batches of drugs will be produced in the amount of more than 10,000 packages. After production reaches full capacity by 2024, the enterprise will be ready to produce up to 2 million packages per year.
Learn more on our website http://technomoscow.com/article/2022_03_02